Literature DB >> 27023870

Saphenous Vein Graft Disease and Serum Erythropoietin Level.

Beuy Joob1, Viroj Wiwanitkit.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27023870      PMCID: PMC5588432          DOI: 10.1159/000445773

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


× No keyword cloud information.
Dear Editor, We read with interest the recent report entitled ‘Saphenous vein graft disease is associated with a low serum erythropoietin level’ by Kocaoğlu et al. [1]. They mentioned that ‘SVG disease was associated with a low serum EPO level, suggesting that a low EPO level could be predictive of and contributes to the pathophysiology of SVG disease’. There are many concerns regarding this report. First, the diagnostic property of the laboratory test kit for the measurement of EPO was not discussed. Second, they forgot to deal with possible confounding factors, such as hematologic disease exemplified by thalassemia, an inherited hemoglobin disorder. A previous study has shown that cases with underlying thalassemia usually present with high EPO level [2]. Because bypass graft surgery can be seen in patients with thalassemia in clinical practice [3] SVG should be expected. Hence, the relationship between SVG and serum EPO levels should be different from the observation by Kocaoğlu et al. [1]. Dear Editor, We would like to thank Joob and Wiwanitkit [1] for their interest in our article. First of all, we used a standardized method to determine EPO levels. Venous blood samples were drawn into a tube without anticoagulant following fasting for ≥8 h from patients undergoing coronary angiography on the same day; all the patients rested in the supine position for ≤1 h at the same time of day (13:00-14:00) to avoid diurnal variation. The EPO level was measured using ELISA. Secondly, thalassemia, an inherited hemoglobin disorder, is a childhood disease and patients usually do not survive into late adulthood [2]. Joob and Wiwanitkit cited the study of Paritpokee et al. [3], which was conducted in pediatric patients. However, we do not come across patients with thalassemia and coronary artery disease in practice since they do not reach older age, and atherosclerosis is rarely encountered in pediatric cases [4]. In our study, no patient had thalassemia. We also looked for other confounding factors and performed multivariate analysis including hemoglobin levels and found that low serum EPO levels were independently associated with saphenous vein graft disease [1]. Editor's Note This response represents solely the opinion of the first and the second author of this article (İ.K. and U.A.).
  5 in total

1.  Serum erythropoietin levels in pediatric patients with beta-thalassemia/hemoglobin E.

Authors:  Nara Paritpokee; Viroj Wiwanitkit; Narudee Bhokaisawan; Chaiyaporn Boonchalermvichian; Paungpayom Preechakas
Journal:  Clin Lab       Date:  2002       Impact factor: 1.138

2.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

Review 3.  Clinical hemoglobinopathies: iron, lungs and new blood.

Authors:  Claudia R Morris; Sylvia T Singer; Mark C Walters
Journal:  Curr Opin Hematol       Date:  2006-11       Impact factor: 3.284

4.  Coronary artery bypass grafting under cardiopulmonary bypass in a patient with beta-thalassemia: report of a case.

Authors:  Tetsuya Horai; Keita Tanaka; Makoto Takeda
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

5.  Saphenous Vein Graft Disease Is Associated with a Low Serum Erythropoietin Level.

Authors:  İbrahim Kocaoğlu; Uğur Arslan; Yavuzer Koza; Mustafa Mücahit Balcı; Gizem Çelik; Sinan Aydoğdu
Journal:  Med Princ Pract       Date:  2015-08-14       Impact factor: 1.927

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.